PRYTELLIX Trademark

Trademark Overview

On Tuesday, July 15, 2014, a trademark application was filed for PRYTELLIX with the United States Patent and Trademark Office. The USPTO has given the PRYTELLIX trademark a serial number of 86337857. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 5, 2018. This trademark is owned by H. Lundbeck A/S. The PRYTELLIX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of brain and nerve diseases and disorders, sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents
prytellix

General Information

Serial Number86337857
Word MarkPRYTELLIX
Filing DateTuesday, July 15, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 5, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and treatment of brain and nerve diseases and disorders, sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 23, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby
DK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events

Event DateEvent Description
Monday, March 5, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 5, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 7, 2017EXTENSION 5 GRANTED
Tuesday, July 18, 2017EXTENSION 5 FILED
Tuesday, July 18, 2017TEAS EXTENSION RECEIVED
Tuesday, July 18, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2016EXTENSION 4 GRANTED
Wednesday, December 28, 2016EXTENSION 4 FILED
Wednesday, December 28, 2016TEAS EXTENSION RECEIVED
Wednesday, June 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2016EXTENSION 3 GRANTED
Wednesday, June 1, 2016EXTENSION 3 FILED
Wednesday, June 1, 2016TEAS EXTENSION RECEIVED
Wednesday, February 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2016EXTENSION 2 GRANTED
Monday, December 28, 2015EXTENSION 2 FILED
Sunday, February 7, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 28, 2015TEAS EXTENSION RECEIVED
Thursday, June 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 17, 2015EXTENSION 1 GRANTED
Tuesday, May 19, 2015EXTENSION 1 FILED
Wednesday, June 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 19, 2015TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 29, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 27, 2014ASSIGNED TO LIE
Tuesday, October 7, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 27, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 26, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 26, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 19, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 19, 2014NON-FINAL ACTION E-MAILED
Friday, September 19, 2014NON-FINAL ACTION WRITTEN
Friday, September 19, 2014ASSIGNED TO EXAMINER
Wednesday, July 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 18, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

prytellix preparations substances pharmaceutical disorders disease disorder treatment prevention central nervous